Register today to unlock Valuecruncher

Choose a username
Your email address
Choose a password
Confirm password
Choose your membership
1 year account US$89 US$49
Lifetime account US$299 US$199
Name on card *
Credit card number *
Credit card expiry *
or Cancel
Our terms & conditions and privacy policy

Unlimited access to all companies
Save your own valuations
Comparison + DCF analysis for S&P500, FTSE350 and others

If you have already registered, please login

ISTA Pharmaceuticals, Inc. (ISTA)

Register today to unlock Valuecruncher and get unlimited access

Get unlimited access to all compartors and data
Save and share valuations as well as comment on others
Alter and save your favourite comparator companies

Already registered? Please login now

Dollar

Point

Implied share price

Sell Overvalued by 91.4%

5% margin of safety What's this?

EV / EBITDA Use Average	ISTA ISTA Pharmaceuticals, Inc.	SNY Sanofi SA (ADR) Change	DNA Genentech, Inc. Change	GILD Gilead Sciences, Inc. Change	AMGN Amgen, Inc. Change
12.32	162.51	6.51	17.08	20.28	9.0
All amounts in millions from last financial year
Implied Share Price	$0.78	$109.54	$69.41	$30.49	$144.30
Market Cap	380	147,662	100,042	80,660	78,417
Net Debt	-3	8,094	-3,369	6,361	2,468
Enterprise Value (EV)	377	80,819	96,673	86,971	80,888
Revenue	160	35,957	13,418	9,702	17,265
EBITDA	2	12,422	5,661	4,288	8,985
Percent	1.4 %	34.5 %	42.2 %	44.2 %	52.0 %
EBIT	0	7,825	5,069	4,010	7,500
Percent	0.0 %	21.8 %	37.8 %	41.3 %	43.4 %
Balance Sheet
Total Assets	153	100,407	21,787	21,239	54,298
Total Liabilities	202	43,069	6,116	11,930	35,238
Shareholders Equity	-49	57,338	15,671	9,309	19,060.0

Comments

No comments yet. Login to comment.